2015
DOI: 10.1504/tbj.2015.078135
|View full text |Cite
|
Sign up to set email alerts
|

RNA aptamer as potential antidote against botulism: an in vivo report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The endopeptidase activity of fLCA and tLCA with endogenous SNAP-25 in the cytosol of neuroblastoma cells was studied by delivering the LCAs inside the cytosol. Cytosolic delivery of 50 nM fLCA or tLCA was achieved using Lipofectamine 2000 (Life Technologies, Grand Island, NY); control cells received no LCA treatment 59 , 60 .…”
Section: Methodsmentioning
confidence: 99%
“…The endopeptidase activity of fLCA and tLCA with endogenous SNAP-25 in the cytosol of neuroblastoma cells was studied by delivering the LCAs inside the cytosol. Cytosolic delivery of 50 nM fLCA or tLCA was achieved using Lipofectamine 2000 (Life Technologies, Grand Island, NY); control cells received no LCA treatment 59 , 60 .…”
Section: Methodsmentioning
confidence: 99%
“…In our earlier studies, by using radioactive based SELEX approach, we have successfully identified three 2’-fluoro-pyrimidines modified RNA aptamers against light chain of botulinum neurotoxin type A (LCA) (27), which not only showed high binding affinity and high specificity to LCA, but also showed strong inhibition effects on enzymatic activity of LCA, and in vivo protection of BoNT intoxication (28). Surface plasmon resonance (SPR) has been developed as an alternative for selection of aptamers (29, 30).…”
Section: Introductionmentioning
confidence: 99%